Prasugrel Compared With Ticagrelor in Patients With ACS Undergoing PCI
A systematic review compared the safety and efficacy of prasugrel and ticagrelor in patients with ACS undergoing PCI.
Interventional
Predictors of Transcatheter Mitral Valve Repair Quality of Life Outcomes
Having atrial fibrillation, using home oxygen, having severe lung disease, or having a permanent pacemaker were predictive of lower health status after transcatheter mitral valve repair.
Security and Privacy Risks Linked to Wearable Healthcare Devices
While wearable technology can provide substantial patient benefit, these devices carry significant privacy and security risks.
Effects of Day of Discharge on Hospital Readmission After Major Cardiac Surgery
For cardiac surgical patients, the likelihood of readmission has no association with day of discharge.
Coronary CTA Reliably Assesses Long-Term Cardiovascular Risk
Coronary computed tomography angiography is a reliable tool to assess long-term cardiovascular risk in suspected CCS.
Complete Revascularization Superior to Culprit-Only Intervention in NSTEMI
Single-stage complete coronary revascularization appears to be superior to culprit-only lesion intervention in multivessel disease ACS.
Heart Failure: Transcatheter MV Repair May Decrease All-Cause Mortality vs Medical Therapy Alone
Transcatheter mitral-valve repair results in a lower rate of hospitalization and lower all-cause mortality than medical therapy alone among patients with heart failure and moderate-to-severe secondary mitral regurgitation who remain symptomatic despite the use of guideline-directed medical therapy.
Can Dermatoscope Magnets Be Used With CV Implanted Electronic Devices?
The safety risk of dermatoscope magnets in patients with cardiovascular implanted electronic devices was examined.
No Differences Between Bivalirudin, UFH Post-PCI After Ticagrelor Pretreatment
There is no difference between heparin and bivalirudin in terms of platelet aggregation or coagulation markers after pretreatment with ticagrelor in patients undergoing PPCI.
Same Day Discharge Post-Elective PCI Safe and Generates Cost Savings
Same day hospital discharge has the potential increase the overall value of PCI care and save US hospitals approximately $577 million if implemented more consistently.
Next post in Interventional
